AR and Familial prostate cancer: Meanwhile, knockdown of each co-activator led to significant reduction in cell proliferation of AR-positive bladder cancer lines, although, inconsistent with the findings in prostate cancer cells, androgen treatment failed to up-regulate the expression levels of these co-activators in these cells [35].